Personalized Cancer Medicine and Targeted Therapy
Personalized medicine is revolutionizing oncology by tailoring treatments to the genetic makeup of each patient’s tumor. This session will cover:
- Targeted Therapies: Drugs designed to target specific mutations in cancer cells, such as HER2-positive breast cancer treatments or PARP inhibitors for BRCA-mutated cancers.
- Immunotherapies Tailored to the Individual: Exploring checkpoint inhibitors and CAR-T cell therapies that are personalized to each patient's immune system.
- Precision Medicine in Clinical Trials: Discussing how clinical trials are being designed around specific genetic markers, improving treatment outcomes.